Document Detail

Keratoacanthoma centrifugum marginatum: response to topical 5-fluorouracil.
MedLine Citation:
PMID:  16631944     Owner:  NLM     Status:  MEDLINE    
Keratoacanthoma centrifugum marginatum (KCM) is a rare variant of keratoacanthoma, characterized by progressive peripheral growth with concomitant healing of the central area of the tumor. We present a patient with KCM who was treated with topical 5% 5-fluorouracil. This is the third reported case of KCM treated with this agent.
Sayuri Yuge; Deise Aparecida Santos Godoy; Maria Carolina Coelho de Melo; Danilo Silveira Sousa; Cleverson Teixeira Soares
Related Documents :
9496534 - A case of a hereditary, late progressing sensory autonomic neuropathy.
1640234 - Progressive anarthria with secondary parkinsonism: a clinico-pathological case report.
21919934 - Sublingual immunotherapy in children with allergic rhinitis: quality of systematic revi...
22217614 - Valproic acid-induced eosinophilic pleural effusion: a case report and review of the li...
830874 - The treatment of pneumopericardium in the newborn infant.
16260884 - Prenatal diagnosis of a fetal chest wall cystic lymphangioma using ultrasonography and ...
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the American Academy of Dermatology     Volume:  54     ISSN:  1097-6787     ISO Abbreviation:  J. Am. Acad. Dermatol.     Publication Date:  2006 May 
Date Detail:
Created Date:  2006-04-24     Completed Date:  2006-05-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7907132     Medline TA:  J Am Acad Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S218-9     Citation Subset:  IM    
Department of Dermatology, Instituto Lauro de Souza Lima, São Paulo, Brazil.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Dermatologic Agents / therapeutic use
Fluorouracil / therapeutic use*
Keratoacanthoma / drug therapy*,  pathology*
Methotrexate / therapeutic use
Skin / pathology
Skin Diseases / drug therapy*,  pathology*
Treatment Failure
Treatment Outcome
Reg. No./Substance:
0/Dermatologic Agents; 51-21-8/Fluorouracil; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Multifocal lymphangioendotheliomatosis with thrombocytopenia.
Next Document:  Primary cutaneous paraganglioma of the scalp.